Nigel Crockett

Distinguished Fellow @Bicycle Therapeutics

Cambridge, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Apr 2025 — Present

Distinguished Fellow @Bicycle Therapeutics

View department →

EDUCATION

N/A

Cambridge University

PhD

N/A

The University of Manchester

Bsc

SKILLS

LicensingCommercializationLifesciencesPharmaceutical IndustryR&DTechnology TransferBusiness StrategyClinical DevelopmentLife SciencesOncologyMolecular BiologyBiochemistryBiotechnologyCompetitive IntelligenceDrug DiscoveryMentoringBusiness DevelopmentDrug DevelopmentMedical DevicesCancerBiopharmaceuticals

ABOUT NIGEL CROCKETT

Chief Business Officer at Bicycle Therapeutics.Founding partner of Tukan Partners, has close to 30 years of commercial experience in the pharma-biotech sector, spanning Europe, the US and Asia, with particular expertise in small molecule and biologicals, in–licensing and out-licensing, early-stage R&D collaborations, medical devices, company financing and acquisitions and a highly respected worldwide network of industry and academic contacts. Founded Tukan Partners in 2005, a business consultancy primarily for the biotech community, with clients across the globe. Formerly VP Business Development at Astex Therapeutics and Commercial Director at Cantab Pharmaceuticals, the immunotherapeutics company. Nigel held a postdoctoral position at the Institute of Biotechnology, Cambridge University, having obtained his PhD in Molecular Biology from Cambridge University in 1989 and a BSc in Chemistry from the University of Manchester in 1986.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Nigel Crockett — Distinguished Fellow at Bicycle Therapeutics in Cambridge, GB | Unifers